MENA Microbiome
From Biomarkers Discovery
to Microbiota-based Therapeutics

Date: 28-29 September 2024

Overview /Agenda

Agenda

7:00 – 8:00 am Registration/Check-in
Time Speaker Talk Time
8:00 – 8:10 am Dr. Souhaila Al Khodor, MENA Microbiome Chair

Dr. Annalisa Terranegra, MENA Microbiome Chair

Dr. Khalid Fakhro, Chief Research Officer, Sidra Medicine

Welcome Notes
8:10 – 8:15 am TBC
8:15 – 8:30 am Dr. Rayana Bou Haka
Head of Office World Health Organization- Qatar
Dr. Abdullatif Al Khal
Deputy Chief Medical Officer
Hamad Medical Corporation, Qatar
Opening remarks
8:30 – 8:45 am TBC TBC
8:45 – 10:30 am Session I: Keeping the balance between health and disease – Role of the Microbiome

Learning objectives:

  • Describe how the microbiome impacts our overall health.
  • Demonstrate the role of the microbiome in chronic gastrointestinal diseases such as pediatric Inflammatory Bowel Disease.
  • Extend to the role of salivary microbiome in patients with Crohn’s disease.

Session Chairs:

  • TBC
8:45 – 9:30 am Prof. Alessio Fasano
Chief of the Division of Pediatric Gastroenterology and Nutrition
Professor of Pediatrics,
Harvard Medical School, MA, USA
Keynote Lecture:

Microbiome, Gut Permeability, And Immune Response: The Triangulation Dictating the Balance Between Health and Disease

9:30 – 9:55 am Dr. Souhaila Al Khodor
Director of the Reproductive and Perinatal Health Division
Sidra Medicine, Qatar
Multi-Omics of microbial and host factors for a better understanding of Pediatric Inflammatory Bowel Disease
9:55 – 10:20 am Dr. Farah Al-Marzooq
Assistant Professor, Department of Medical Microbiology and Immunology
United Arab Emirates University, UAE
Salivary microbiome signature in patients with Crohn’s disease
10:20 – 10:30 am Short Oral Talk O1
10:30 – 11:00 am Coffee break

Poster viewing and exhibition visit

11:00 am – 2:00 pm Session II: Diet, Lifestyle & the Microbiome

Learning objectives:

  • Describe the effect of diet on the microbiome composition.
  • Explain how dietary intakes are measured.
  • Illustrate the relationship between diet and the microbiome in chronic diseases such as obesity and diabetes.

Session Chairs:

  • TBC
11:00 – 11:25 am Dr. Heli Viljakainen
Group leader, Department of Food and Nutrition
University of Helsinki, Finland
Associations of central Childhood obesity and habitual food consumption with saliva microbiota and its enzymatic profiles.
11:25 – 11:50 am Dr. Vibeke H. Telle-Hansen
Associate Professor
Oslo Metropolitan University, Norway
Testing the beneficial effect of PUFA on the microbiome and cholesterol levels in healthy individuals: A randomized crossover trial.
11:50 am – 12:00 pm Short Oral Talk O2
12:00 – 1:00 pm Lunch

Poster viewing and judging

1:00 – 1:25 pm Dr. Annalisa Terranegra
Principal Investigator Precision Nutrition
Sidra Medicine, Qatar
Precision nutrition approach to pediatric type 1 diabetes
1:25 – 1:50 pm Dr. Mohammad T Albataineh
Assistant Professor, Molecular Biology and Genetics, College of Medicine and Health Sciences
Khalifa University, UAE
Uncovering the relationship between gut microbial dysbiosis, metabolomics, and dietary intake in type 2 diabetes mellitus and in healthy volunteers
1:50 – 2:00 pm Short Oral Talk O3
2:00 – 4:35 pm Session III: Bugs as drugs: Microbiome-based Therapeutics

Learning objectives:

  • Explain the definition of prebiotics, probiotics and symbiotics.
  • Illustrate the use of microbes as therapeutics options.
  • Demonstrate how treating with microbes affects IBD, autism and obesity.

Session Chairs:

  • TBC
2:00 – 2:25 pm Dr. Amine Zorgani
Founder – The Microbiome Mavericks Consultant Biocodex Microbiota Institute, Belgium
Microbiome therapeutics: Past, Present, and Future
2:25 – 2:50 pm Dr. Mamoun Elawad
Chief of the Division of Pediatric Gastroenterology and Nutrition Sidra Medicine, Qatar
Faecal Material Transplantation in Inflammatory Bowel disease
2:50 – 3:15 pm Prof. Sunny Wong
Associate Professor and Assistant Dean at the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
Effects of Synbiotic Supplementation on Metabolic Syndrome Traits and Gut Microbial Profile among Overweight and Obese Hong Kong Chinese Individuals: A Randomized Trial
3:15 – 3:45 pm Coffee Break

Poster viewing and judging

3:45 – 4:10 pm Dr. Elisabetta Volpe
Head of Molecular Neuroimmunology Laboratory
IRCCS Fondazione Santa Lucia, Italy
Microbiome in Pediatric Autism: can microbial intervention improve the social behaviour?
4:10 – 4:35 pm Dr. Nezar Al-Hebshi
Associate Professor- Co Director, Oral Microbiome Research Laboratory
Temple University, PA, USA
Role of the Oral Microbiome in Health and Disease: can we quantify dysbiosis?
4:35 – 5:00 pm Prof. Marvin Edeas
Department Endocrinology, Metabolism and Diabetes
Université de Paris, INSERM, Institute Cochin, France
Targeting Microbiota Dysbiosis: Barriers and Perspectives
5:00 – 5:45 pm Panel Discussion

Panel members: TBC

  • Fostering collaboration in the MENA region.
  • Creating the MENA Human Microbiome Consortium.
5:45 – 6:00 pm Closing remarks for Day 1 MENA Microbiome conference Chairs

7:00 – 8:00 am Registration/Check-in
8:00 am – 12:00 pm Session IV: A deep dive into the human gut: Lessons from the Microbiome  

Learning objectives:

  • Describe the microbiome composition of a healthy gut.
  • Summarize the different members of the gut microbiome.
  • Evaluate the application of systems biology approaches to study the microbiome.

Session Chairs:

  • TBC
8:00 – 8:45 am Prof. Peer Bork
Director of EMBL Heidelberg, Germany
Keynote Lecture II:

Gut microbiome analysis for human health and wellbeing

8:45 – 9:10 am Prof. Emmanuelle Maguin
Director, French National Institute for Agriculture, Food,
and Environment (INRAE), France
The food and microbiome interplay for health
9:10 – 9:35 am Dr. Mohammad Tauqeer Alam
Assistant Professor, Biology Department,
UAE University, UAE
Identifying microbial markers for gut microbiome associated diseases using systems biology approaches
9:35 – 10:00 am Dr. Greg Tasian
Attending Pediatric Urologist, Division of Urology
Children’s Hospital of Philadelphia, PA, USA
The Gut-Kidney Axis of Kidney Stone Disease: A Pathway to Novel Diagnostics and Therapeutics
10:00 – 10:05 am Patient Success story Manipulation of the microbiome through diet can improve clinical outcomes: A story from an IBD-Autistic patient at Sidra Medicine
10:05 – 10:35 am Coffee break

Poster viewing and judging

10:35 – 11:00 am Prof. Nahla Mansour
Professor of Microbial Molecular Biology
National Research Center, Egypt
Gut Microbiome Analysis in Type 2 Diabetes Egyptians: Towards Personalized Medicine
11:00 – 11:25 am Prof. Amein K. Al-Ali
Professor of Clinical Biochemistry, College of Medicine, Imam Abdulrahman bin Faisal University, Saudi Arabia
Characterization of the Gut microbiome composition in Diabetic patients from KSA
11:25 – 11:50 am Prof. Mohammad Issa El Mouzan
Professor of Pediatrics, College of Medicine,
King Saud University, Saudi Arabia

Gut Virome and Mycobiome in the Saudi pediatric population
11:50 – 12:00 pm Short Oral Talk O4
12:00 – 12:10 pm Short Oral Talk O5
12:10 – 12:20 pm Short Oral Talk O6
12:20 – 1:30 pm Lunch

Poster viewing and judging

1:00 – 3:05 pm Session V: Microbiome in Women and neonatal Health

Learning objectives:
•    List the major vaginal microbes in healthy women
•    Explain the major microbiome changes during pregnancy
•    Describe the role of the microbiome in prematurity

1:30 -1:55 pm Prof. Phillip Bennett
Director of Institute of Reproductive and Developmental Biology, Professor of Obstetrics and Gynaecology Imperial College London, UK
Microbiome aspects of fertility, miscarriage, and preterm birth
1:55 – 2:20 pm Dr. Maha Al Asmakh
Department Head of Biomedical Sciences Associate Professor, Qatar University, Qatar
Salivary Microbiome in pregnancy
2:20 – 2:45 pm Prof. Erika Isolauri
Professor of Pediatrics
Head of the Department of Clinical Medicine, Faculty of Medicine, University of Turku, Finland
Resilience to risk exposures in the preterm child through the microbiome
2:45 – 3:10 pm Dr. Ahmed Mustafa
Sequencing Core Director of the Microbiome Center
Children’s Hospital of Philadelphia, PA, USA
Empowering Global Disease Surveillance: Leveraging Microbial Genomics, Big Data Mining, and Environmental Microbiome Analysis to Understand Infectious Diseases
3:10 – 3:35 pm Dr.  Ibrahim Hassan
Senior attending Physician, Microbiology and Virology, Sidra Medicine, Qatar
Antimicrobial stewardship and microbiome in the pediatric population: Where are we?
3:35 – 4:00 pm Coffee Break

Poster viewing and judging

4:00 – 5:30 pm Microbiome Documentary Screening:

The Invisible Extinction

Martin Blaser
Professor, Medicine and Microbiology,
Robert Wood Johnson Medical School, NJ, USA

Maria Gloria Dominguez Bello
Professor, Department of Biochemistry and Microbiology,
Rutgers School of Environmental and Biological Sciences, NJ, USA

5:30 – 5:45 pm Closing remarks for Day 2
&
Posters Award Announcement
MENA Microbiome conference Chairs